37 results on '"Koshkina O"'
Search Results
2. Management Decisions under Uncertainty Using Controlling Tools
- Author
-
Koshkina, N. V., primary, Koshkina, O. V., additional, and Tkhorikov, B. A., additional
- Published
- 2023
- Full Text
- View/download PDF
3. The Mechanism of Continuous Activity in the Management of the Company’s Financial Stability
- Author
-
Koshkina, O. O., primary, Kredina, A. A., additional, Koshkina, N. V., additional, and Tkhorikov, B. A., additional
- Published
- 2022
- Full Text
- View/download PDF
4. The Use Of Payment Cards In Kazakhstan: Analysis And Forecast
- Author
-
Kredina, A. A., primary, Koshkina, O. V., additional, and Vasa, László, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Copy number variation (CNV) as a promising genetic marker: distribution, validation methods and candidate genes in genomes of livestock species (review)
- Author
-
Koshkina, O. A., primary, Deniskova, T. E., additional, and Zinovieva, N. A., additional
- Published
- 2020
- Full Text
- View/download PDF
6. Multifunctional poly(lactic-co-glycolic acid) nanoparticles for imaging and therapy: formulation and applications
- Author
-
Vries, I.J.M. de, Srinivas, M., Koshkina, O., Tagit, O., Swider, E.A., Vries, I.J.M. de, Srinivas, M., Koshkina, O., Tagit, O., and Swider, E.A.
- Abstract
Radboud University, 10 februari 2020, Promotor : Vries, I.J.M. de Co-promotores : Srinivas, M., Koshkina, O., Tagit, O., Contains fulltext : 215256.pdf (publisher's version ) (Open Access)
- Published
- 2020
7. In vivo clearance of (19)F MRI imaging nanocarriers is strongly influenced by nanoparticle ultrastructure
- Author
-
Staal, A.H.J., Becker, K., Tagit, O., Riessen, N.K. van, Koshkina, O., Veltien, A.A., Bouvain, P., Cortenbach, K.R.G., Scheenen, T.W.J., Flogel, U., Temme, S., Srinivas, M., Staal, A.H.J., Becker, K., Tagit, O., Riessen, N.K. van, Koshkina, O., Veltien, A.A., Bouvain, P., Cortenbach, K.R.G., Scheenen, T.W.J., Flogel, U., Temme, S., and Srinivas, M.
- Abstract
Contains fulltext : 229164.pdf (Publisher’s version ) (Open Access), Perfluorocarbons hold great promise both as imaging agents, particularly for (19)F MRI, and in therapy, such as oxygen delivery. (19)F MRI is unique in its ability to unambiguously track and quantify a tracer while maintaining anatomic context, and without the use of ionizing radiation. This is particularly well-suited for inflammation imaging and quantitative cell tracking. However, perfluorocarbons, which are best suited for imaging - like perfluoro-15-crown-5 ether (PFCE) - tend to have extremely long biological retention. Here, we showed that the use of a multi-core PLGA nanoparticle entrapping PFCE allows for a 15-fold reduction of half-life in vivo compared to what is reported in literature. This unexpected rapid decrease in (19)F signal was observed in liver, spleen and within the infarcted region after myocardial infarction and was confirmed by whole body NMR spectroscopy. We demonstrate that the fast clearance is due to disassembly of the ~200 nm nanoparticle into ~30 nm domains that remain soluble and are cleared quickly. We show here that the nanoparticle ultrastructure has a direct impact on in vivo clearance of its cargo i.e. allowing fast release of PFCE, and therefore also bringing the possibility of multifunctional nanoparticle-based imaging to translational imaging, therapy and diagnostics.
- Published
- 2020
8. Nanoparticles for 'two color' F-19 magnetic resonance imaging: Towards e combined imaging of biodistribution and degradation
- Author
-
Koshkina, O., White, P.B., Staal, A.H.J., Schweins, Ralf, Swider, E.A., Tirotta, Ilaria, Veltien, A.A., Riessen, N.K. van, Heerschap, A., Bombelli, Francesca Baldelli, Srinivas, M., Koshkina, O., White, P.B., Staal, A.H.J., Schweins, Ralf, Swider, E.A., Tirotta, Ilaria, Veltien, A.A., Riessen, N.K. van, Heerschap, A., Bombelli, Francesca Baldelli, and Srinivas, M.
- Abstract
Contains fulltext : 217381.pdf (publisher's version ) (Open Access)
- Published
- 2020
9. Continuous-Flow Production of Perfluorocarbon-Loaded Polymeric Nanoparticles: From the Bench to Clinic
- Author
-
Hoogendijk, E., Swider, E.A., Staal, A.H.J., White, P.B., Riessen, N.K. van, Glasser, G., Lieberwirth, I., Musyanovych, A., Serra, C.A., Srinivas, M., Koshkina, O., Hoogendijk, E., Swider, E.A., Staal, A.H.J., White, P.B., Riessen, N.K. van, Glasser, G., Lieberwirth, I., Musyanovych, A., Serra, C.A., Srinivas, M., and Koshkina, O.
- Abstract
Contains fulltext : 229134.pdf (publisher's version ) (Open Access), Perfluorocarbon-loaded nanoparticles are powerful theranostic agents, which are used in the therapy of cancer and stroke and as imaging agents for ultrasound and (19)F magnetic resonance imaging (MRI). Scaling up the production of perfluorocarbon-loaded nanoparticles is essential for clinical translation. However, it represents a major challenge as perfluorocarbons are hydrophobic and lipophobic. We developed a method for continuous-flow production of perfluorocarbon-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles using a modular microfluidic system, with sufficient yields for clinical use. We combined two slit interdigital micromixers with a sonication flow cell to achieve efficient mixing of three phases: liquid perfluorocarbon, PLGA in organic solvent, and aqueous surfactant solution. The production rate was at least 30 times higher than with the conventional formulation. The characteristics of nanoparticles can be adjusted by changing the flow rates and type of solvent, resulting in a high PFC loading of 20-60 wt % and radii below 200 nm. The nanoparticles are nontoxic, suitable for (19)F MRI and ultrasound imaging, and can dissolve oxygen. In vivo (19)F MRI with perfluoro-15-crown-5 ether-loaded nanoparticles showed similar biodistribution as nanoparticles made with the conventional method and a fast clearance from the organs. Overall, we developed a continuous, modular method for scaled-up production of perfluorocarbon-loaded nanoparticles that can be potentially adapted for the production of other multiphase systems. Thus, it will facilitate the clinical translation of theranostic agents in the future.
- Published
- 2020
10. Features of Epidemic Process of Tuberculosis in the Territory with High Prevalence of HIV Infection
- Author
-
Shugaeva, S. N., primary, Savilov, E. D., additional, Koshkina, O. G., additional, Suzdalnitskiy, A. E., additional, and Chemezova, N. N., additional
- Published
- 2019
- Full Text
- View/download PDF
11. Multicore Liquid Perfluorocarbon-Loaded Multimodal Nanoparticles for Stable Ultrasound and F-19 MRI Applied to In Vivo Cell Tracking
- Author
-
Koshkina, O., Lajoinie, Guillaume, Bombelli, Francesca Baldelli, Swider, E.A., Cruz, Luis J., White, P.B., Dolen, Y., Dinther, E.A.W. van, Riessen, N.K. van, Heerschap, A., Korte, C.L. de, Figdor, C.G., Vries, I.J.M. de, Srinivas, M., Koshkina, O., Lajoinie, Guillaume, Bombelli, Francesca Baldelli, Swider, E.A., Cruz, Luis J., White, P.B., Dolen, Y., Dinther, E.A.W. van, Riessen, N.K. van, Heerschap, A., Korte, C.L. de, Figdor, C.G., Vries, I.J.M. de, and Srinivas, M.
- Abstract
Contains fulltext : 204774.pdf (publisher's version ) (Open Access)
- Published
- 2019
12. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
- Author
-
Swider, E.A., Koshkina, O., Tel, J., Cruz, L.J., Vries, I.J.M. de, Srinivas, M., Swider, E.A., Koshkina, O., Tel, J., Cruz, L.J., Vries, I.J.M. de, and Srinivas, M.
- Abstract
Item does not contain fulltext, Nano- and microparticles have increasingly widespread applications in nanomedicine, ranging from drug delivery to imaging. Poly(lactic-co-glycolic acid) (PLGA) particles are the most widely-applied type of particles due to their biocompatibility and biodegradability. Here, we discuss the preparation of PLGA particles, and various modifications to tailor particles for applications in biological systems. We highlight new preparation approaches, including microfluidics and PRINT method, and modifications of PLGA particles resulting in novel or responsive properties, such as Janus or upconversion particles. Finally, we describe how the preparation methods can- and should-be adapted to tailor the properties of particles for the desired biomedical application. Our aim is to enable researchers who work with PLGA particles to better appreciate the effects of the selected preparation procedure on the final properties of the particles and its biological implications. STATEMENT OF SIGNIFICANCE: Nanoparticles are increasingly important in the field of biomedicine. Particles made of polymers are in the spotlight, due to their biodegradability, biocompatibility, versatility. In this review, we aim to discuss the range of formulation techniques, manipulations, and applications of poly(lactic-co-glycolic acid) (PLGA) particles, to enable a researcher to effectively select or design the optimal particles for their application. We describe the various techniques of PLGA particle synthesis and their impact on possible applications. We focus on recent developments in the field of PLGA particles, and new synthesis techniques that have emerged over the past years. Overall, we show how the chemistry of PLGA particles can be adapted to solve pressing biological needs.
- Published
- 2018
13. Design of triphasic poly(lactic-co-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications
- Author
-
Swider, E.A., Staal, A.H.J., Riessen, N.K. van, Jacobs, L, White, P.B., Fokkink, R., Dinther, Eric van, Figdor, C.G., Vries, I.J.M. de, Koshkina, O., Srinivas, M., Swider, E.A., Staal, A.H.J., Riessen, N.K. van, Jacobs, L, White, P.B., Fokkink, R., Dinther, Eric van, Figdor, C.G., Vries, I.J.M. de, Koshkina, O., and Srinivas, M.
- Abstract
Contains fulltext : 183916.pdf (publisher's version ) (Open Access)
- Published
- 2018
14. Clinically-Applicable Perfluorocarbon-Loaded Nanoparticles For In vivo Photoacoustic, (19)F Magnetic Resonance And Fluorescent Imaging
- Author
-
Swider, E.A., Daoudi, K., Staal, A.H.J., Koshkina, O., Riessen, N.K. van, Dinther, E.A. van, Vries, I.J.M. de, Korte, C.L. de, Srinivas, M., Swider, E.A., Daoudi, K., Staal, A.H.J., Koshkina, O., Riessen, N.K. van, Dinther, E.A. van, Vries, I.J.M. de, Korte, C.L. de, and Srinivas, M.
- Abstract
Contains fulltext : 193511.pdf (publisher's version ) (Open Access), Photoacoustic imaging (PAI) is an emerging biomedical imaging technique that is now coming to the clinic. It has a penetration depth of a few centimeters and generates useful endogenous contrast, particularly from melanin and oxy-/deoxyhemoglobin. Indocyanine green (ICG) is a Food and Drug Administration-approved contrast agents for human applications, which can be also used in PAI. It is a small molecule dye with limited applications due to its fast clearance, rapid protein binding, and bleaching effect. Methods: Here, we entrap ICG in a poly(lactic-co-glycolic acid) nanoparticles together with a perfluorocarbon (PFC) using single emulsion method. These nanoparticles and nanoparticle-loaded dendritic cells were imaged with PA, (19)F MR, and fluorescence imaging in vitro and in vivo. Results: We formulated particles with an average diameter of 200 nm. The encapsulation of ICG within nanoparticles decreased its photobleaching and increased the retention of the signal within cells, making it available for applications such as cell imaging. As little as 0.1x10(6) cells could be detected in vivo with PAI using automated spectral unmixing. Furthermore, we observed the accumulation of ICG signal in the lymph node after subcutaneous injection of nanoparticles. Conclusion: We show that we can label primary human dendritic cells with the nanoparticles and image them in vitro and in vivo, in a multimodal manner. This work demonstrates the potential of combining PAI and (19)F MRI for cell imaging and lymph node detection using nanoparticles that are currently produced at GMP-grade for clinical use.
- Published
- 2018
15. Perfluorocarbon/Gold Loading for Noninvasive in Vivo Assessment of Bone Fillers Using 19F Magnetic Resonance Imaging and Computed Tomography
- Author
-
Mastrogiacomo, S., Dou, W., Koshkina, O., Boerman, O.C., Jansen, J.A., Heerschap, A., Srinivas, M., Walboomers, X.F., Mastrogiacomo, S., Dou, W., Koshkina, O., Boerman, O.C., Jansen, J.A., Heerschap, A., Srinivas, M., and Walboomers, X.F.
- Abstract
Contains fulltext : 177175.pdf (Publisher’s version ) (Open Access), Calcium phosphate cement (CPC) is used in bone repair because of its biocompatibility. However, high similarity between CPC and the natural osseous phase results in poor image contrast in most of the available in vivo imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). For accurate identification and localization during and after implantation in vivo, a composition with enhanced image contrast is needed. In this study, we labeled CPC with perfluoro-15-crown-5-ether-loaded (PFCE) poly(latic-co-glycolic acid) nanoparticles (hydrodynamic radius 100 nm) and gold nanoparticles (diameter 40 nm), as 19F MRI and CT contrast agents, respectively. The resulting CPC/PFCE/gold composite is implanted in a rat model for in vivo longitudinal imaging. Our findings show that the incorporation of the two types of different nanoparticles did result in adequate handling properties of the cement. Qualitative and quantitative long-term assessment of CPC/PFCE/gold degradation was achieved in vivo and correlated to the new bone formation. Finally, no adverse biological effects on the bone tissue are observed via histology. In conclusion, an easy and efficient strategy for following CPC implantation and degradation in vivo is developed. As all materials used are biocompatible, this CPC/PFCE/gold composite is clinically applicable.
- Published
- 2017
16. Tuning the Surface of Nanoparticles: Impact of Poly(2-ethyl-2-oxazoline) on Protein Adsorption in Serum and Cellular Uptake
- Author
-
Koshkina, O., Westmeier, D., Lang, T., Bantz, C., Hahlbrock, A., Wurth, C., Resch-Genger, U., Braun, U., Thiermann, R., Weise, C., Eravci, M., Mohr, B., Schlaad, H., Stauber, R.H., Docter, D., Bertin, A., Maskos, M., Koshkina, O., Westmeier, D., Lang, T., Bantz, C., Hahlbrock, A., Wurth, C., Resch-Genger, U., Braun, U., Thiermann, R., Weise, C., Eravci, M., Mohr, B., Schlaad, H., Stauber, R.H., Docter, D., Bertin, A., and Maskos, M.
- Abstract
Item does not contain fulltext, Due to the adsorption of biomolecules, the control of the biodistribution of nanoparticles is still one of the major challenges of nanomedicine. Poly(2-ethyl-2-oxazoline) (PEtOx) for surface modification of nanoparticles is applied and both protein adsorption and cellular uptake of PEtOxylated nanoparticles versus nanoparticles coated with poly(ethylene glycol) (PEG) and non-coated positively and negatively charged nanoparticles are compared. Therefore, fluorescent poly(organosiloxane) nanoparticles of 15 nm radius are synthesized, which are used as a scaffold for surface modification in a grafting onto approach. With multi-angle dynamic light scattering, asymmetrical flow field-flow fractionation, gel electrophoresis, and liquid chromatography-mass spectrometry, it is demonstrated that protein adsorption on PEtOxylated nanoparticles is extremely low, similar as on PEGylated nanoparticles. Moreover, quantitative microscopy reveals that PEtOxylation significantly reduces the non-specific cellular uptake, particularly by macrophage-like cells. Collectively, studies demonstrate that PEtOx is a very effective alternative to PEG for stealth modification of the surface of nanoparticles.
- Published
- 2016
17. Temperature-Triggered Protein Adsorption on Polymer-Coated Nanoparticles in Serum
- Author
-
Koshkina, O., Lang, T., Thiermann, R., Docter, D., Stauber, R.H., Secker, C., Schlaad, H., Weidner, S., Mohr, B., Maskos, M., Bertin, A., Koshkina, O., Lang, T., Thiermann, R., Docter, D., Stauber, R.H., Secker, C., Schlaad, H., Weidner, S., Mohr, B., Maskos, M., and Bertin, A.
- Abstract
Item does not contain fulltext, The protein corona, which forms on the nanoparticle's surface in most biological media, determines the nanoparticle's physicochemical characteristics. The formation of the protein corona has a significant impact on the biodistribution and clearance of nanoparticles in vivo. Therefore, the ability to influence the formation of the protein corona is essential to most biomedical applications, including drug delivery and imaging. In this study, we investigate the protein adsorption on nanoparticles with a hydrodynamic radius of 30 nm and a coating of thermoresponsive poly(2-isopropyl-2-oxazoline) in serum. Using multiangle dynamic light scattering (DLS) we demonstrate that heating of the nanoparticles above their phase separation temperature induces the formation of agglomerates, with a hydrodynamic radius of 1 mum. In serum, noticeably stronger agglomeration occurs at lower temperatures compared to serum-free conditions. Cryogenic transmission electron microscopy (cryo-TEM) revealed a high packing density of agglomerates when serum was not present. In contrast, in the presence of serum, agglomerated nanoparticles were loosely packed, indicating that proteins are intercalated between them. Moreover, an increase in protein content is observed upon heating, confirming that protein adsorption is induced by the alteration of the surface during phase separation. After cooling and switching the surface back, most of the agglomerates were dissolved and the main fraction returned to the original size of approximately 30 nm as shown by asymmetrical flow-field flow fractionation (AF-FFF) and DLS. Furthermore, the amounts of adsorbed proteins are similar before and after heating the nanoparticles to above their phase-separation temperature. Overall, our results demonstrate that the thermoresponsivity of the polymer coating enables turning the corona formation on nanoparticles on and off in situ. As the local heating of body areas can be easily done in vivo, the thermoresponsive co
- Published
- 2015
18. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions
- Author
-
Bantz, C., Koshkina, O., Lang, T., Galla, H.J., Kirkpatrick, C.J., Stauber, R.H., Maskos, M., Bantz, C., Koshkina, O., Lang, T., Galla, H.J., Kirkpatrick, C.J., Stauber, R.H., and Maskos, M.
- Abstract
Contains fulltext : 139274.pdf (publisher's version ) (Open Access), Due to the recent widespread application of nanomaterials to biological systems, a careful consideration of their physiological impact is required. This demands an understanding of the complex processes at the bio-nano interface. Therefore, a comprehensive and accurate characterization of the material under physiological conditions is crucial to correlate the observed biological impact with defined colloidal properties. As promising candidates for biomedical applications, two SiO2-based nanomaterial systems were chosen for extensive size characterization to investigate the agglomeration behavior under physiological conditions. To combine the benefits of different characterization techniques and to compensate for their respective drawbacks, transmission electron microscopy, dynamic light scattering and asymmetric flow field-flow fractionation were applied. The investigated particle systems were (i) negatively charged silica particles and (ii) poly(organosiloxane) particles offering variable surface modification opportunities (positively charged, polymer coated). It is shown that the surface properties primarily determine the agglomeration state of the particles and therefore their effective size, especially under physiological conditions. Thus, the biological identity of a nanomaterial is clearly influenced by differentiating surface properties.
- Published
- 2014
19. Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems
- Author
-
Dwivedi, M.V., Harishchandra, R.K., Koshkina, O., Maskos, M., Galla, H.J., Dwivedi, M.V., Harishchandra, R.K., Koshkina, O., Maskos, M., and Galla, H.J.
- Abstract
Item does not contain fulltext, The alveolar lung surfactant (LS) is a complex lipid protein mixture that forms an interfacial monolayer reducing the surface tension to near zero values and thus preventing the lungs from collapse. Due to the expanding field of nanotechnology and the corresponding unavoidable exposure of human beings from the air, it is crucial to study the potential effects of nanoparticles (NPs) on the structural organization of the lung surfactant system. In the present study, we investigated both, the domain structure in pure DPPC monolayers as well as in lung surfactant model systems. In the pure lipid system we found that two different sized hydrophobic polymeric nanoparticles with diameter of ~12 nm and ~136 nm have contrasting effect on the functional and structural behavior. The small nanoparticles inserted into fluid domains at the LE-LC phase transition are not visibly disturbing the phase transition but disrupting the domain morphology of the LE phase. The large nanoparticles led to an expanded isotherm and to a significant decrease in the line tension and thus to a drastic disruption of the domain structures at a much lower number of nanoparticles with respect to the lipid. The surface activity of the model LS films again showed drastic variations due to presence of different sized NPs illustrated by the film balance isotherms and the atomic force microscopy. AFM revealed laterally profuse multilayer protrusion formation on compression but only in the presence of 136 nm sized nanoparticles. Moreover we investigated the vesicle insertion process into a preformed monolayer. A severe inhibition was observed only in the presence of ~136 nm NPs compared to minor effects in the presence of ~12 nm NPs. Our study clearly shows that the size of the nanoparticles made of the same material determines the interaction with biological membranes.
- Published
- 2014
20. The Environmental Impact of Medical Imaging Agents and the Roadmap to Sustainable Medical Imaging.
- Author
-
Pichler V, Martinho RP, Temming L, Segers T, Wurm FR, and Koshkina O
- Subjects
- Humans, Diagnostic Imaging methods, Magnetic Resonance Imaging methods, Radiopharmaceuticals, Environmental Pollution prevention & control, Contrast Media adverse effects, Contrast Media chemistry
- Abstract
Medical imaging agents, i.e., contrast agents for magnetic resonance imaging (MRI) and radiopharmaceuticals, play a vital role in the diagnosis of diseases. Yet, they mostly contain harmful and non-biodegradable substances, such as per- and polyfluoroalkyl substances (PFAS), heavy metals or radionuclides. As a result of their increasing clinical use, these agents are entering various water bodies and soil, posing risks to environment and human health. Here, the environmental effects of the application of imaging agents are outlined for the major imaging modalities, and the respective chemistry of the contrast agents with environmental implications is linked. Recommendations are introduced for the design and application of contrast agents: the 3Cs of imaging agents: control, change, and combine; and recent approaches for more sustainable imaging strategies are highlighted. This combination of measures should engage an open discussion, inspire solutions to reduce pollution by imaging agents, and increase awareness for the impact of toxic waste related to imaging agents., (© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbH.)
- Published
- 2025
- Full Text
- View/download PDF
21. Diagnostic et prise en charge du syndrome des ovaires polykystiques.
- Author
-
Dason ES, Koshkina O, Chan C, and Sobel M
- Abstract
Competing Interests: Intérêts concurrents:: Mara Sobel déclare avoir reçu des honoraires de la société Bayer. Aucun autre intérêt concurrent n’a été déclaré. Cet article a été révisé par des pairs.
- Published
- 2024
- Full Text
- View/download PDF
22. Diagnosis and management of polycystic ovarian syndrome.
- Author
-
Dason ES, Koshkina O, Chan C, and Sobel M
- Subjects
- Female, Humans, Polycystic Ovary Syndrome diagnosis, Polycystic Ovary Syndrome therapy
- Abstract
Competing Interests: Competing interests:: Mara Sobel reports an honorarium from Bayer. No other competing interests were declared.
- Published
- 2024
- Full Text
- View/download PDF
23. Real-time 31 P NMR reveals different gradient strengths in polyphosphoester copolymers as potential MRI-traceable nanomaterials.
- Author
-
Rheinberger T, Flögel U, Koshkina O, and Wurm FR
- Abstract
Polyphosphoesters (PPEs) are used in tissue engineering and drug delivery, as polyelectrolytes, and flame-retardants. Mostly polyphosphates have been investigated but copolymers involving different PPE subclasses have been rarely explored and the reactivity ratios of different cyclic phospholanes have not been reported. We synthesized binary and ternary PPE copolymers using cyclic comonomers, including side-chain phosphonates, phosphates, thiophosphate, and in-chain phosphonates, through organocatalyzed ring-opening copolymerization. Reactivity ratios were determined for all cases, including ternary PPE copolymers, using different nonterminal models. By combining different comonomers and organocatalysts, we created gradient copolymers with adjustable amphiphilicity and microstructure. Reactivity ratios ranging from 0.02 to 44 were observed for different comonomer sets. Statistical ring-opening copolymerization enabled the synthesis of amphiphilic gradient copolymers in a one-pot procedure, exhibiting tunable interfacial and magnetic resonance imaging (MRI) properties. These copolymers self-assembled in aqueous solutions, 31 P MRI imaging confirmed their potential as MRI-traceable nanostructures. This systematic study expands the possibilities of PPE-copolymers for drug delivery and theranostics., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
24. Phylogenetic Analysis of Russian Native Sheep Breeds Based on mtDNA Sequences.
- Author
-
Koshkina O, Deniskova T, Dotsev A, Kunz E, Selionova M, Medugorac I, and Zinovieva N
- Subjects
- Sheep genetics, Animals, Phylogeny, Animals, Domestic genetics, Russia, DNA, Mitochondrial genetics, Mitochondria genetics
- Abstract
Eurasia is represented by all climatic zones and various environments. A unique breed variety of farm animals has been developed in Russia, whose territory covers a large area of the continent. A total of 69 local breeds and types of dairy, wool, and meat sheep ( Ovis aries ) are maintained here. However, the genetic diversity and maternal origin of these local breeds have not been comprehensively investigated. In this study, we describe the diversity and phylogeny of Russian sheep breeds inhabiting different geographical regions based on the analysis of complete sequences of mitochondrial genomes (mtDNA). Complete mtDNA sequences of the studied sheep were obtained using next-generation sequencing technology (NGS). All investigated geographical groups of sheep were characterized by high haplotype (Hd = 0.9992) and nucleotide diversity (π = 0.00378). Analysis of the AMOVA results showed that genetic diversity was majorly determined by within-population differences (77.87%). We identified 128 haplotypes in all studied sheep. Haplotypes belonged to the following haplogroups: B (64.8%), A (28.9%), C (5.5%), and D (0.8%). Haplogroup B was predominant in the western part of Russia. A high level of mtDNA polymorphism in the studied groups of local sheep indicates the presence of a significant reserve of unique genotypes in Russia, which is to be explored.
- Published
- 2023
- Full Text
- View/download PDF
25. Biodegradable polyphosphoester micelles act as both background-free 31 P magnetic resonance imaging agents and drug nanocarriers.
- Author
-
Koshkina O, Rheinberger T, Flocke V, Windfelder A, Bouvain P, Hamelmann NM, Paulusse JMJ, Gojzewski H, Flögel U, and Wurm FR
- Subjects
- Drug Delivery Systems methods, Magnetic Resonance Imaging, Drug Carriers chemistry, Micelles, Polymers chemistry
- Abstract
In vivo monitoring of polymers is crucial for drug delivery and tissue regeneration. Magnetic resonance imaging (MRI) is a whole-body imaging technique, and heteronuclear MRI allows quantitative imaging. However, MRI agents can result in environmental pollution and organ accumulation. To address this, we introduce biocompatible and biodegradable polyphosphoesters, as MRI-traceable polymers using the
31 P centers in the polymer backbone. We overcome challenges in31 P MRI, including background interference and low sensitivity, by modifying the molecular environment of31 P, assembling polymers into colloids, and tailoring the polymers' microstructure to adjust MRI-relaxation times. Specifically, gradient-type polyphosphonate-copolymers demonstrate improved MRI-relaxation times compared to homo- and block copolymers, making them suitable for imaging. We validate background-free imaging and biodegradation in vivo using Manduca sexta. Furthermore, encapsulating the potent drug PROTAC allows using these amphiphilic copolymers to simultaneously deliver drugs, enabling theranostics. This first report paves the way for polyphosphoesters as background-free MRI-traceable polymers for theranostic applications., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
26. Process evaluation for the adaptation, testing and dissemination of a mobile health platform to support people with HIV and tuberculosis in Irkutsk, Siberia.
- Author
-
Hodges J, Waldman AL, Koshkina O, Suzdalnitsky A, Schwendinger J, Vitko S, Plenskey A, Plotnikova Y, Moiseeva E, Koshcheyev M, Sebekin S, Zhdanova S, Ogarkov O, Heysell S, and Dillingham R
- Subjects
- Humans, Siberia epidemiology, Coinfection, HIV Infections epidemiology, HIV Infections therapy, Telemedicine, Tuberculosis epidemiology, Tuberculosis therapy
- Abstract
Objectives: We developed and tested a mobile health-based programme to enhance integration of HIV and tuberculosis (TB) care and to promote a patient-centred approach in a region of high coinfection burden. Phases of programme development included planning, stakeholder interviews and platform re-build, testing and iteration., Setting: In Irkutsk, Siberia, HIV/TB coinfection prevalence is high relative to the rest of the Russian Federation., Participants: Pilot testing occurred for a cohort of 60 people with HIV and TB., Results: Key steps emerged to ensure the mobile health-based programme could be operational and adequately adapted for the context, including platform language adaptation, optimisation of server management, iteration of platform features, and organisational practice integration. Pilot testing of the platform rebuild yielded favourable patient perceptions of usability and acceptability at 6 months (n=47 surveyed), with 18 of 20 items showing scores above 4 (on a scale from 1 to 5) on average. Development of this mobile health-based programme for integrated care of infections highlighted the importance of several considerations for tailoring these interventions contextually, including language adaptation and technological capacity, but also, importantly, contextualised patient preferences related to privacy and communication with peers and/or providers, existing regional capacity for care coordination of different comorbidities, and infection severity and treatment requirements., Conclusions: Our experience demonstrated that integration of care for TB and HIV can be well served by using multimodal mobile health-based programmes, which can enhance communication and streamline workflow between providers across multiple collaborating institutions and improve continuity between inpatient and outpatient care settings. Further study of programme impact on contextual disease-related stigma and social isolation as well as evaluation of implementation on a broader scale for HIV care is currently under way., Trial Registration Number: NCT03819374., Competing Interests: Competing interests: Authors RD, ALW and JS provide consulting services to Warm Health Technology, an entity that supports dissemination of PositiveLinks. RD has also received an investigator-initiated grant from Gilead, which is unrelated to this study., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
27. Combination of Multiple Microsatellite Analysis and Genome-Wide SNP Genotyping Helps to Solve Wildlife Crime: A Case Study of Poaching of a Caucasian tur ( Capra caucasica ) in Russian Mountain National Park.
- Author
-
Rodionov A, Deniskova T, Dotsev A, Volkova V, Petrov S, Kharzinova V, Koshkina O, Abdelmanova A, Solovieva A, Shakhin A, Bardukov N, and Zinovieva N
- Abstract
Poaching is one of the major types of wildlife crime in Russia. Remnants of goats (presumably the wild endemic species, the Caucasian tur) were found in an area of the Caucasian mountains. The case study involves a suspected poacher whose vehicle was found to have two duffel bags containing pieces of a carcass, which he claimed was that of a goat from his flock. The aim of the forensic genetic analysis for this case was to (i) establish individual identity and (ii) perform species identification. DNA typing based on fourteen microsatellites revealed that STR-genotypes generated from pieces of evidence found at crime scene fully matched those obtained from the evidence seized from the suspect. The results of genome-wide SNP-genotyping, using Illumina Goat SNP50 BeadChip, provided evidence that the poached animal was a wild Caucasian tur ( Capra caucasica ). Thus, based on comprehensive molecular genetic analysis, evidence of poaching was obtained and sent to local authorities. To our knowledge, this case study is the first to attempt to use DNA chips in wildlife forensics of ungulates.
- Published
- 2021
- Full Text
- View/download PDF
28. Analysis of Homozygous-by-Descent (HBD) Segments for Purebred and Crossbred Pigs in Russia.
- Author
-
Bakoev S, Kolosov A, Bakoev F, Kostyunina O, Bakoev N, Romanets T, Koshkina O, and Getmantseva L
- Abstract
Intensive selection raises the efficiency of pig farming considerably, but it also promotes the accumulation of homozygosity, which can lead to an increase in inbreeding and the accumulation of deleterious variation. The analysis of segments homozygous-by-descent (HBD) and non-HBD segments in purebred and crossbred pigs is of great interest. Research was carried out on 657 pigs, of which there were Large White (LW, n = 280), Landrace (LR, n = 218) and F1 female (♂LR × ♀LW) (F1, n = 159). Genotyping was performed using the GeneSeek
® GGP Porcine HD Genomic Profiler v1 (Illumina Inc., USA). To identify HBD segments and estimate autozygosity (inbreeding coefficient), we used the multiple HBD classes model. LW pigs exhibited 50,420 HBD segments, an average of 180 per animal; LR pigs exhibited 33,586 HBD segments, an average of 154 per animal; F1 pigs exhibited 21,068 HBD segments, an average of 132 per animal. The longest HBD segments in LW were presented in SSC1, SSC13 and SSC15; in LR, in SSC1; and in F1, in SSC15. In these segments, 3898 SNPs localized in 1252 genes were identified. These areas overlap with 441 QTLs (SSC1-238 QTLs; SSC13-101 QTLs; and SSC15-102 QTLs), including 174 QTLs for meat and carcass traits (84 QTLs-fatness), 127 QTLs for reproduction traits (100 QTLs-litter traits), 101 for production traits (69 QTLs-growth and 30 QTLs-feed intake), 21 QTLs for exterior traits (9 QTLs-conformation) and 18 QTLs for health traits (13 QTLs-blood parameters). Thirty SNPs were missense variants. Whilst estimating the potential for deleterious variation, six SNPs localized in the NEDD4, SEC11C, DCP1A, CCT8, PKP4 and TENM3 genes were identified, which may show deleterious variation. A high frequency of potential deleterious variation was noted for LR in DCP1A, and for LW in TENM3 and PKP4. In all cases, the genotype frequencies in F1 were intermediate between LR and LW. The findings presented in our work show the promise of genome scanning for HBD as a strategy for studying population history, identifying genomic regions and genes associated with important economic traits, as well as deleterious variation.- Published
- 2021
- Full Text
- View/download PDF
29. In vivo clearance of 19 F MRI imaging nanocarriers is strongly influenced by nanoparticle ultrastructure.
- Author
-
Staal AHJ, Becker K, Tagit O, Koen van Riessen N, Koshkina O, Veltien A, Bouvain P, Cortenbach KRG, Scheenen T, Flögel U, Temme S, and Srinivas M
- Subjects
- Liver, Magnetic Resonance Imaging, Spleen, Fluorocarbons, Nanoparticles
- Abstract
Perfluorocarbons hold great promise both as imaging agents, particularly for
19 F MRI, and in therapy, such as oxygen delivery.19 F MRI is unique in its ability to unambiguously track and quantify a tracer while maintaining anatomic context, and without the use of ionizing radiation. This is particularly well-suited for inflammation imaging and quantitative cell tracking. However, perfluorocarbons, which are best suited for imaging - like perfluoro-15-crown-5 ether (PFCE) - tend to have extremely long biological retention. Here, we showed that the use of a multi-core PLGA nanoparticle entrapping PFCE allows for a 15-fold reduction of half-life in vivo compared to what is reported in literature. This unexpected rapid decrease in19 F signal was observed in liver, spleen and within the infarcted region after myocardial infarction and was confirmed by whole body NMR spectroscopy. We demonstrate that the fast clearance is due to disassembly of the ~200 nm nanoparticle into ~30 nm domains that remain soluble and are cleared quickly. We show here that the nanoparticle ultrastructure has a direct impact on in vivo clearance of its cargo i.e. allowing fast release of PFCE, and therefore also bringing the possibility of multifunctional nanoparticle-based imaging to translational imaging, therapy and diagnostics., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
30. Urine colorimetry for levofloxacin pharmacokinetics and personalized dosing in people with drug-resistant tuberculosis.
- Author
-
Rao P, Zhdanova S, Ogarkov O, Orlova E, Ebers A, Stroup S, Mirawdaly S, Aartsen DV, Koshkina O, Suzdalnitsky A, Moiseeva E, Dillingham R, and Heysell SK
- Subjects
- Antitubercular Agents therapeutic use, Colorimetry, Drug Monitoring, Female, Humans, ROC Curve, Levofloxacin pharmacokinetics, Tuberculosis, Multidrug-Resistant drug therapy
- Abstract
Background: Levofloxacin is a preferred drug for multidrug-resistant (MDR)-tuberculosis (TB) with bactericidal activity that correlates with the pharmacokinetic exposures of serum peak concentration (C
max ) and total area under the concentration time curve (AUC0-24 ). Pharmacokinetic exposures can be measured to personalize dosing to reach targets, but this practice requires venepuncture, chromatographic or mass spectrometry equipment, and technical expertise. We sought to demonstrate the accuracy of using urine colorimetry as a more feasible estimation of levofloxacin exposure., Method: A colorimetric method using bromocresol green was tested on spiked urine samples with levofloxacin measured using a spectrophotometer. This method was tested in urine samples of healthy volunteers given one 750 mg dose of levofloxacin with urine collected at 0-4 h, 4-8 h, and 8-24 h intervals, and concomitant serum samples were collected and analyzed by high-performance liquid chromatography. Validation of this assay was done in a cohort of people living with human immunodeficiency virus (PLWH), initiating a levofloxacin containing MDR-TB regimen., Results: Urine colorimetry was reproducible in spiked samples and the calibration was curve linear for levofloxacin concentrations ranging from 7.8 μg/ml to 250 μg/ml, with r = 0.98. In healthy volunteers, correlation between urine absorbance values and serum AUC0-24 was highest in urine collected between 4 and 8 h (r = 0.91, P = 0.01), yet in PLWH, urine collected between 0 and 4 h had highest correlation (r = 0.66, P = 0.05). The area under the receiver operating characteristics curve was >0.8 in the derivation, as well as the validation cohort for the urine absorbance values identifying people with total serum exposure below target., Conclusion: Urine colorimetry was highly sensitive in predicting target serum concentrations. Colorimetric methods to determine levofloxacin in urine may improve the feasibility of therapeutic drug monitoring and personalized dose adjustment in TB endemic settings., Competing Interests: None- Published
- 2020
- Full Text
- View/download PDF
31. Nanoparticles for "two color" 19 F magnetic resonance imaging: Towards combined imaging of biodistribution and degradation.
- Author
-
Koshkina O, White PB, Staal AHJ, Schweins R, Swider E, Tirotta I, Tinnemans P, Fokkink R, Veltien A, van Riessen NK, van Eck ERH, Heerschap A, Metrangolo P, Baldelli Bombelli F, and Srinivas M
- Subjects
- Cell Survival, Cells, Cultured, Fluorocarbons chemistry, Humans, Leukocytes, Mononuclear chemistry, Leukocytes, Mononuclear cytology, Molecular Structure, Nanoparticles chemistry, Particle Size, Surface Properties, Color, Fluorine-19 Magnetic Resonance Imaging, Fluorocarbons metabolism, Leukocytes, Mononuclear metabolism, Nanoparticles metabolism
- Abstract
The use of polymeric nanoparticles (NPs) as therapeutics has been steadily increasing over past decades. In vivo imaging of NPs is necessary to advance the therapeutic performance.
19 F Magnetic Resonance Imaging (19 F MRI) offers multiple advantages for in vivo imaging. However, design of a probe for both biodistribution and degradation has not been realized yet. We developed polymeric NPs loaded with two fluorocarbons as promising imaging tools to monitor NP biodistribution and degradation by19 F MRI. These 200 nm NPs consist of poly(lactic-co-glycolic acid) (PLGA) loaded with perfluoro-15-crown-5 ether (PFCE) and PERFECTA. PERFECTA/PFCE-PLGA NPs have a fractal sphere structure, in which both fluorocarbons are distributed in the polymeric matrix of the fractal building blocks, which differs from PFCE-PLGA NPs and is unique for fluorocarbon-loaded colloids. This structure leads to changes of magnetic resonance properties of both fluorocarbons after hydrolysis of NPs. PERFECTA/PFCE-PLGA NPs are colloidally stable in serum and biocompatible. Both fluorocarbons show a single resonance in19 F MRI that can be imaged separately using different excitation pulses. In the future, these findings may be used for biodistribution and degradation studies of NPs by19 F MRI in vivo using "two color" labeling leading to improvement of drug delivery agents., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
32. Proof of concept for stereotactic body radiation therapy in the treatment of functional neuroendocrine neoplasms.
- Author
-
Myrehaug S, Hallet J, Chu W, Yong E, Law C, Assal A, Koshkina O, Louie AV, and Singh S
- Abstract
Dysregulated hormonal production remains a challenge in the management of neuroendocrine neoplasms (NEN). We report 4 cases of patients with functional NEN treated with stereotactic body radiation therapy (SBRT) to either the primary/dominant metastatic site of disease or the end organ of hormonal release. No significant toxicities were observed during or after treatment. Each patient has had biochemical, clinical and radiographic response to therapy, providing proof of concept that SBRT is an effective therapeutic strategy for functional neuroendocrine neoplasms., Competing Interests: Authors’ disclosure of potential conflicts of interest No authors report conflicts of interest related to this work. Sten Myrehaug reports personal fees/grants from Novartis and Ipsen. Julie Hallet reports personal fees/grants from Novartis/Ipsen/Baxter. Calvin Law reports personal fees from Taiho/Ipsen/Novartis/Amgen/Gilead. Alexander Louie reports personal fees from Astra Zeneca and Varian Medical Systems. Simron Singh reports personal fees/grants from Novartis/Ipsen/EMD Sorono. Other authors have nothing to report., (© 2020 Old City Publishing, Inc.)
- Published
- 2020
33. Clinically-Applicable Perfluorocarbon-Loaded Nanoparticles For In vivo Photoacoustic, 19 F Magnetic Resonance And Fluorescent Imaging.
- Author
-
Swider E, Daoudi K, Staal AHJ, Koshkina O, van Riessen NK, van Dinther E, de Vries IJM, de Korte CL, and Srinivas M
- Abstract
Photoacoustic imaging (PAI) is an emerging biomedical imaging technique that is now coming to the clinic. It has a penetration depth of a few centimeters and generates useful endogenous contrast, particularly from melanin and oxy-/deoxyhemoglobin. Indocyanine green (ICG) is a Food and Drug Administration-approved contrast agents for human applications, which can be also used in PAI. It is a small molecule dye with limited applications due to its fast clearance, rapid protein binding, and bleaching effect. Methods: Here, we entrap ICG in a poly(lactic- co -glycolic acid) nanoparticles together with a perfluorocarbon (PFC) using single emulsion method. These nanoparticles and nanoparticle-loaded dendritic cells were imaged with PA,
19 F MR, and fluorescence imaging in vitro and in vivo . Results: We formulated particles with an average diameter of 200 nm. The encapsulation of ICG within nanoparticles decreased its photobleaching and increased the retention of the signal within cells, making it available for applications such as cell imaging. As little as 0.1x106 cells could be detected in vivo with PAI using automated spectral unmixing. Furthermore, we observed the accumulation of ICG signal in the lymph node after subcutaneous injection of nanoparticles. Conclusion: We show that we can label primary human dendritic cells with the nanoparticles and image them in vitro and in vivo , in a multimodal manner. This work demonstrates the potential of combining PAI and19 F MRI for cell imaging and lymph node detection using nanoparticles that are currently produced at GMP-grade for clinical use., Competing Interests: Competing Interests: The authors have declared that no competing interest exists.- Published
- 2018
- Full Text
- View/download PDF
34. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications.
- Author
-
Swider E, Koshkina O, Tel J, Cruz LJ, de Vries IJM, and Srinivas M
- Subjects
- Animals, Humans, Microfluidics instrumentation, Microfluidics methods, Biocompatible Materials chemistry, Materials Testing, Polylactic Acid-Polyglycolic Acid Copolymer chemistry
- Abstract
Nano- and microparticles have increasingly widespread applications in nanomedicine, ranging from drug delivery to imaging. Poly(lactic-co-glycolic acid) (PLGA) particles are the most widely-applied type of particles due to their biocompatibility and biodegradability. Here, we discuss the preparation of PLGA particles, and various modifications to tailor particles for applications in biological systems. We highlight new preparation approaches, including microfluidics and PRINT method, and modifications of PLGA particles resulting in novel or responsive properties, such as Janus or upconversion particles. Finally, we describe how the preparation methods can- and should-be adapted to tailor the properties of particles for the desired biomedical application. Our aim is to enable researchers who work with PLGA particles to better appreciate the effects of the selected preparation procedure on the final properties of the particles and its biological implications., Statement of Significance: Nanoparticles are increasingly important in the field of biomedicine. Particles made of polymers are in the spotlight, due to their biodegradability, biocompatibility, versatility. In this review, we aim to discuss the range of formulation techniques, manipulations, and applications of poly(lactic-co-glycolic acid) (PLGA) particles, to enable a researcher to effectively select or design the optimal particles for their application. We describe the various techniques of PLGA particle synthesis and their impact on possible applications. We focus on recent developments in the field of PLGA particles, and new synthesis techniques that have emerged over the past years. Overall, we show how the chemistry of PLGA particles can be adapted to solve pressing biological needs., (Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
35. Design of triphasic poly(lactic- co -glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications.
- Author
-
Swider E, Staal AHJ, Koen van Riessen N, Jacobs L, White PB, Fokkink R, Janssen GJ, van Dinther E, Figdor CG, de Vries IJM, Koshkina O, and Srinivas M
- Abstract
Poly(lactic- co -glycolic acid) (PLGA) particles are very widely used, particularly for drug delivery, including commercial clinical formulations. Adding perfluorocarbon (PFC) enables in vivo imaging and quantification of the PLGA particles through
19 F NMR, MRS or MRI. PFCs are both hydrophobic and lipophobic at the same time. This property makes their encapsulation in particles challenging, as it requires the addition of a third immiscible phase during the emulsification process. Here we explore how different parameters affect the miniemulsion formation of particles loaded with perfluoro-15-crown-5-ether (PFCE). By changing the concentration of surfactant and type of solvent, we were able to control the radius of synthesized particles, between 85-200 nm. We assessed stability and release from the particles at different pH values, showing that hydrophobic agents are released from the particles by diffusion rather than degradation. With cell experiments, we show that primary human dendritic cells take up the particles without any apparent effect, including on cell migration. In summary, the control of synthesis conditions leads to particles with sufficient PFCE encapsulation, which are suitable for drug loading and cell labeling, and do not affect cell viability or functionality. Finally, these nanoparticles can be produced at GMP-grade for clinical use., Competing Interests: There are no conflicts of interest to declare., (This journal is © The Royal Society of Chemistry.)- Published
- 2018
- Full Text
- View/download PDF
36. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions.
- Author
-
Bantz C, Koshkina O, Lang T, Galla HJ, Kirkpatrick CJ, Stauber RH, and Maskos M
- Abstract
Due to the recent widespread application of nanomaterials to biological systems, a careful consideration of their physiological impact is required. This demands an understanding of the complex processes at the bio-nano interface. Therefore, a comprehensive and accurate characterization of the material under physiological conditions is crucial to correlate the observed biological impact with defined colloidal properties. As promising candidates for biomedical applications, two SiO2-based nanomaterial systems were chosen for extensive size characterization to investigate the agglomeration behavior under physiological conditions. To combine the benefits of different characterization techniques and to compensate for their respective drawbacks, transmission electron microscopy, dynamic light scattering and asymmetric flow field-flow fractionation were applied. The investigated particle systems were (i) negatively charged silica particles and (ii) poly(organosiloxane) particles offering variable surface modification opportunities (positively charged, polymer coated). It is shown that the surface properties primarily determine the agglomeration state of the particles and therefore their effective size, especially under physiological conditions. Thus, the biological identity of a nanomaterial is clearly influenced by differentiating surface properties.
- Published
- 2014
- Full Text
- View/download PDF
37. Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems.
- Author
-
Dwivedi MV, Harishchandra RK, Koshkina O, Maskos M, and Galla HJ
- Subjects
- 1,2-Dipalmitoylphosphatidylcholine chemistry, Animals, Hydrophobic and Hydrophilic Interactions, Membranes, Artificial, Phase Transition, Swine, Models, Biological, Nanoparticles chemistry, Pulmonary Surfactant-Associated Proteins chemistry
- Abstract
The alveolar lung surfactant (LS) is a complex lipid protein mixture that forms an interfacial monolayer reducing the surface tension to near zero values and thus preventing the lungs from collapse. Due to the expanding field of nanotechnology and the corresponding unavoidable exposure of human beings from the air, it is crucial to study the potential effects of nanoparticles (NPs) on the structural organization of the lung surfactant system. In the present study, we investigated both, the domain structure in pure DPPC monolayers as well as in lung surfactant model systems. In the pure lipid system we found that two different sized hydrophobic polymeric nanoparticles with diameter of ~12 nm and ~136 nm have contrasting effect on the functional and structural behavior. The small nanoparticles inserted into fluid domains at the LE-LC phase transition are not visibly disturbing the phase transition but disrupting the domain morphology of the LE phase. The large nanoparticles led to an expanded isotherm and to a significant decrease in the line tension and thus to a drastic disruption of the domain structures at a much lower number of nanoparticles with respect to the lipid. The surface activity of the model LS films again showed drastic variations due to presence of different sized NPs illustrated by the film balance isotherms and the atomic force microscopy. AFM revealed laterally profuse multilayer protrusion formation on compression but only in the presence of 136 nm sized nanoparticles. Moreover we investigated the vesicle insertion process into a preformed monolayer. A severe inhibition was observed only in the presence of ~136 nm NPs compared to minor effects in the presence of ~12 nm NPs. Our study clearly shows that the size of the nanoparticles made of the same material determines the interaction with biological membranes., (Copyright © 2014 Biophysical Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.